RARE vs TDOC · rev $350.0M vs rev $1.22B
Ultragenyx (RARE) versus Teladoc Inc (TDOC) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Teladoc Inc (TDOC) is a health information services company listed on NYSE.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported TDOC revenue for 2026-06-30 was $1.22B. Net income was -$102.7M. Revenue was up 98.9% from 2026-03-31 to 2026-06-30. TDOC currently screens at market cap $1.38B.
RARE currently screens at market cap $2.79B. TDOC currently screens at market cap $1.38B.
Not investment advice. Open the RARE and TDOC stock pages for the full models.
Not investment advice.